Prescription
Targeted cancer therapy (EGFR tyrosine kinase inhibitor)
Osimertinib
Last reviewed April 2026
Who is this for?
What is this drug?
Osimertinib (sold as Tagrisso in Nigeria) is a targeted cancer medicine that works by blocking a specific abnormal protein (called EGFR) found on some cancer cells, which stops the cancer from growing and spreading.
What is it used for?
A specific type of lung cancer called non-small cell lung cancer (NSCLC) that has a particular gene change (EGFR mutation)
Prescription Required
A doctor's prescription is required to obtain this drug legally.